Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ralf Baron

Showing results (121-130 of 321) with videos related to

Pageof 33
Sort By:
British Journal of Pharmacology|November 15, 2025
Novel approaches for drug development against chronic primary pain: A systematic reviewValéria Tékus, Éva Borbély, Andreas Goebel, et al.
Frontiers in Psychiatry|April 4, 2022
Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic ReviewMagdalena Mroczek, Ignazio Maniscalco, Manon Sendel, et al.
Cephalalgia : an International Journal of Headache|February 18, 2020
Do doctors treat themselves differently than their patients? Study on the self-treatment of migraine among German neurologists and pain specialistsLeonie C Hansen, Charly Gaul, Esther Pogatzki-Zahn, et al.
Journal of Pain Research|August 16, 2019
Stratification of patients with unclassified pain in the FabryScan databaseJulia Forstenpointner, Paul Moeller, Manon Sendel, et al.
Journal of Neurology|August 19, 2004
Idiopathic restless legs syndrome: abnormalities in central somatosensory processingJörn Schattschneider, Andre Bode, Gunnar Wasner, et al.
Pain Reports|February 26, 2019
Sensitized vasoactive C-nociceptors: key fibers in peripheral neuropathic painJulia Forstenpointner, Dennis Naleschinski, Gunnar Wasner, et al.
Current Medical Research and Opinion|July 10, 2012
Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgiaRainer Sabatowski, Guy Hans, Ingrid Tacken, et al.
Clinical Drug Investigation|May 13, 2009
Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trialAndreas Binder, Jean Bruxelle, Peter Rogers, et al.
Current Medical Research and Opinion|June 3, 2009
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT studyRalf Baron, Victor Mayoral, Göran Leijon, et al.
Journal of Neuro-Oncology|August 8, 2002
Docetaxel-induced nail changes--a neurogenic mechanism: a case reportGunnar Wasner, Felix Hilpert, Jörn Schattschneider, et al.
Pageof 33

Showing results (121-130 of 321) with videos related to

Sort By:
Pageof 33
British Journal of Pharmacology|November 15, 2025
Novel approaches for drug development against chronic primary pain: A systematic reviewValéria Tékus, Éva Borbély, Andreas Goebel, et al.
Frontiers in Psychiatry|April 4, 2022
Neuropsychiatric Symptoms and Their Association With Sex, Age, and Enzyme Replacement Therapy in Fabry Disease: A Systematic ReviewMagdalena Mroczek, Ignazio Maniscalco, Manon Sendel, et al.
Cephalalgia : an International Journal of Headache|February 18, 2020
Do doctors treat themselves differently than their patients? Study on the self-treatment of migraine among German neurologists and pain specialistsLeonie C Hansen, Charly Gaul, Esther Pogatzki-Zahn, et al.
Journal of Pain Research|August 16, 2019
Stratification of patients with unclassified pain in the FabryScan databaseJulia Forstenpointner, Paul Moeller, Manon Sendel, et al.
Journal of Neurology|August 19, 2004
Idiopathic restless legs syndrome: abnormalities in central somatosensory processingJörn Schattschneider, Andre Bode, Gunnar Wasner, et al.
Pain Reports|February 26, 2019
Sensitized vasoactive C-nociceptors: key fibers in peripheral neuropathic painJulia Forstenpointner, Dennis Naleschinski, Gunnar Wasner, et al.
Current Medical Research and Opinion|July 10, 2012
Safety and efficacy outcomes of long-term treatment up to 4 years with 5% lidocaine medicated plaster in patients with post-herpetic neuralgiaRainer Sabatowski, Guy Hans, Ingrid Tacken, et al.
Clinical Drug Investigation|May 13, 2009
Topical 5% lidocaine (lignocaine) medicated plaster treatment for post-herpetic neuralgia: results of a double-blind, placebo-controlled, multinational efficacy and safety trialAndreas Binder, Jean Bruxelle, Peter Rogers, et al.
Current Medical Research and Opinion|June 3, 2009
5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: an open-label, non-inferiority two-stage RCT studyRalf Baron, Victor Mayoral, Göran Leijon, et al.
Journal of Neuro-Oncology|August 8, 2002
Docetaxel-induced nail changes--a neurogenic mechanism: a case reportGunnar Wasner, Felix Hilpert, Jörn Schattschneider, et al.
Pageof 33